Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,834,232
  • Shares Outstanding, K 562,120
  • Annual Sales, $ 100,065 M
  • Annual Income, $ 4,517 M
  • 36-Month Beta 1.01
  • Price/Sales 0.54
  • Price/Cash Flow 9.17
  • Price/Book 2.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.42
  • Number of Estimates 11
  • High Estimate 2.43
  • Low Estimate 2.40
  • Prior Year 1.90
  • Growth Rate Est. (year over year) +27.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.41 +4.05%
on 09/25/18
97.22 -1.10%
on 10/10/18
+1.21 (+1.27%)
since 09/18/18
3-Month
72.00 +33.54%
on 08/01/18
97.22 -1.10%
on 10/10/18
+18.26 (+23.44%)
since 07/18/18
52-Week
57.61 +66.90%
on 10/19/17
97.22 -1.10%
on 10/10/18
+38.38 (+66.44%)
since 10/18/17

Most Recent Stories

More News
Express Scripts Holding Company Announces Third Quarter 2018 Earnings Release Details

Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today its intention to release its 2018 third quarter financial results on Wednesday, October 31, 2018, after the market closes....

ESRX : 96.15 (+0.40%)
Watch for Express Scripts to Potentially Pullback After Gaining 2.65% Yesterday

Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $94.07 to a high of $96.05. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of...

ESRX : 96.15 (+0.40%)
After Yesterday's Rally of 2.65% Shares Could Potentially Pullback

Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $94.07 to a high of $96.05. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of...

ESRX : 96.15 (+0.40%)
What's in Store for Express Scripts' (ESRX) Q3 Earnings?

Express Scripts (ESRX) likely to see soft PBM revenues in the third quarter of 2018; guidance strong.

ESRX : 96.15 (+0.40%)
MASI : 117.19 (-2.37%)
BAX : 70.47 (-2.72%)
BIO : 284.42 (-1.14%)
Express Scripts Introduces Medicare PDP Offerings for 2019

Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.

ESRX : 96.15 (+0.40%)
SRDX : 64.94 (-1.68%)
VEEV : 93.50 (-2.14%)
MASI : 117.19 (-2.37%)
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael

In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication...

ESRX : 96.15 (+0.40%)
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael

In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication...

ESRX : 96.15 (+0.40%)
Express Scripts Introduces Medicare Part D Plan Offerings for 2019

Express Scripts (NASDAQ: ESRX) today introduced its Express Scripts Medicare® Prescription Drug Plan (PDP) offerings for 2019, offering seniors three high-value options for coverage and savings.

ESRX : 96.15 (+0.40%)
Express Scripts' Accredo & Akcea Tie Up to Distribute TEGSEDI

Express Scripts (ESRX) likely to gain market traction through distribution of TEGSEDI.

ESRX : 96.15 (+0.40%)
VEEV : 93.50 (-2.14%)
MASI : 117.19 (-2.37%)
ISRG : 522.29 (-3.80%)
Innisfree M&A Incorporated Expands Proxy Solicitation Team

Innisfree M&A Incorporated, the leading proxy solicitation/investor relations firm, today announced that Gabrielle E. Wolf has joined the firm as a Director. Ms. Wolf was previously an attorney...

ESRX : 96.15 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ESRX with:

Business Summary

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy...

See More

Key Turning Points

2nd Resistance Point 97.05
1st Resistance Point 96.60
Last Price 96.15
1st Support Level 95.58
2nd Support Level 95.01

See More

52-Week High 97.22
Last Price 96.15
Fibonacci 61.8% 82.09
Fibonacci 50% 77.42
Fibonacci 38.2% 72.74
52-Week Low 57.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar